β2-adrenoreceptor agonist ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of mitochondrial biogenesis - 13/11/21
pages | 12 |
Iconographies | 8 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Chemotherapy-induced neuropathic pain is a debilitating and common side effect of cancer treatment and so far no effective drug is available for treatment of the serious side effect. Previous studies have demonstrated β2-adrenoreceptor (ADRB2) agonists can attenuate neuropathic pain. However, the role of ADRB2 in paclitaxel -induced neuropathic pain (PINP) remains unclear. In this study, we investigated the effect of formoterol, a long-acting ADRB2 agonist, and related mechanisms in PINP. A rat model of PINP was established by intraperitoneal injection of paclitaxel (2 mg/kg) every other day with a final cumulative dose of 8 mg/kg. Hind paw withdrawal thresholds (PWTs) in response to von Frey filament stimuli were used to evaluate mechanical allodynia. Western blot was used to examine the expression of ADRB2, peroxisome proliferator–activated receptor coactivator-1α (PGC-1α), nuclear respiratory factors 1 (NRF1) and mitochondrial transcription factor A (TFAM) and the immunofluorescence was to detect the cellular localization of ADRB2 and PGC-1α in the spinal cord. Moreover, we measured mitochondrial DNA (mtDNA) copy number by qPCR. In our study, formoterol attenuated established PINP and delayed the onset of PINP. Formoterol restored ADRB2 expression as well as mtDNA copy number and PGC-1α, NRF1, and TFAM protein expression, which are major genes involved in mitochondrial biogenesis, in the spinal cord of PINP rats. Moreover, we found the analgesic effect of formoterol against PINP was partially abolished by PGC-1α inhibitor SR-18292. Collectively, these results demonstrated the activation of ADRB2 with formoterol ameliorates PINP at least partially through induction of mitochondrial biogenesis.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | ADRB2 activation with formoterol attenuated established PINP. |
• | Induction of PGC-1α-mediated MB mitigated PINP. |
• | PGC-1α inhibitor partially abolished the analgesic effect of formoterol. |
• | Formoterol increased mitochondrial content in spinal cord of PINP rats. |
• | Formoterol ameliorated PINP partially through induction of MB. |
Chemical compounds studied in this article : Formoterol fumarate dihydrate (PubChem SID: 24278448), ZLN005 (PubChem CID: 899323), SR-18292 (PubChem CID: 129896798)
Keywords : Paclitaxel, Neuropathic pain, Formoterol, β2-adrenoreceptor, Mitochondrial biogenesis, PGC-1α
Plan
Vol 144
Article 112331- décembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?